Evaluating Mesorectal Lymph Nodes in Rectal Cancer Before and After Neoadjuvant Chemoradiation Using Thin-Section T2-Weighted Magnetic Resonance Imaging
- 1 June 2008
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 71 (2) , 456-461
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancerEuropean Journal of Surgical Oncology, 2007
- The expanding role of PET technology in the management of patients with colorectal cancerAnnals of Oncology, 2007
- Rectal Carcinoma: MRI with Histologic Correlation Before and After Chemoradiation TherapyAmerican Journal of Roentgenology, 2007
- Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal CancerJournal of Clinical Oncology, 2006
- Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancerBritish Journal of Radiology, 2005
- Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapyInternational Journal of Colorectal Disease, 2005
- High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?European Journal of Radiology, 2004
- Neoadjuvant Therapy for Rectal Cancer: Histologic Response of the Primary Tumor Predicts Nodal StatusDiseases of the Colon & Rectum, 2004
- Rectal Carcinoma: Thin-Section MR Imaging for Staging in 28 PatientsRadiology, 1999
- Preoperative Radiation and Chemotherapy in the Treatment of Adenocarcinoma of the RectumAnnals of Surgery, 1995